Science & Research

A new report from Arcview Group and BDS Analytics suggests that the global cannabinoid market could reach $14.9 billion by the end of 2019 – a 36 percent increase over last year.

A recent study shows that nearly two-thirds of military veterans in California have replaced prescription medications with cannabis in the treatment of chronic pain, anxiety, PTSD, depression, and insomnia.

Archaeologists in China have discovered evidence of human cannabis use and cultivation dating back to 500 B.C.; researchers indicate that cannabis appears to have been used during burial rituals.

Australian researchers are seeking 300 participants for a years-long trial investigating the effectiveness of CBD as a treatment for veterans suffering from PTSD.

UC Riverside researchers have received a $744,000 grant to research the long-term impact of cannabis use on metabolic disorders like Type 2 diabetes.

A recent U.S. survey found that if cannabis were made federally legal, the vast majority of consumers (85 percent) would use it as a treatment option for specific ailments, not necessarily just for recreation.

Researchers at the University of Washington have mapped the gene networks of cannabis that are responsible for cannabinoid and terpenoid production.

The earmarked funds will cover research into cannabis as a migraine treatment, harm reduction for youth, education, and an investigation into the rare condition cannabinoid hyperemesis syndrome, which can lead to severe nausea and vomiting after cannabis use.

A study in the American Journal of Psychiatry has shown CBD to be effective in reducing the cravings of opioid addicts, with participants citing a two- to three-fold reduction in cravings on average compared to participants who received a placebo.

A recent study into the historical origins of cannabis has traced the plant back just over 28 million years ago to the Tibetan Plateau, 10,500 feet above sea level.

Researchers at the University of Washington are undertaking a study to measure the effects of cannabis use during pregnancy.

Researchers at the University of Washington are investigating the efficacy of CBD for Fragile X syndrome, a type of autism that may be linked to cannabinoid deficiencies.

New York-based cannabis investor Bob Broderick has announced a $9 million donation to MIT and Harvard for researching the cannabis plant.

A strong majority of cannabis consumers say they prefer cannabis use to alcohol consumption; 45 percent said they would likely replace some of their drinking with cannabis in the future.

According to a recent University of Colorado Boulder study, 81.7 percent of respondents enjoy combining the use of cannabis with their exercise regimens.

Medical cannabis patients in Minnesota have reported a “significant reduction” in the severity of their cancer symptoms.

The investment will span five years and will cover applications for basic science, clinical, health services, and policy cannabis research.

Some 40 percent of U.S. adults who are 21 or older say they are interested in experimenting with CBD products.

A stoned driving study launching in Colorado hopes to help determine an accurate roadside cannabis intoxication test.

Experts are using DNA to better understand the many differences in how we experience cannabis as individuals.

Raphael Mechoulam, the first person to isolate and synthesize THC, has joined the scientific advisory committee of Israel-based medical cannabis producer Cannbit.

Researchers at the University of New Mexico have uncovered a stronger-than-expected correlation of symptom relief with THC.

Researchers at the University of California, Berkeley have extracted cannabinoids from brewers yeast.

A study of the Denver area found that the presence of a medical cannabis dispensary indicated temporarily higher crime rates. This could, however, be the result of increased police targeting or simply a temporary effect of a new, cash-only business.